Boundless Bio, Inc. (BOLD) AI Dilution Summary

Estimated cash was $72,626,000 as of 2026-06-30, the last reported balance-sheet date, against estimated monthly burn of $6,991,000. The funding channel in place is an at-the-market program with Jefferies LLC, authorised to $14,500,000, with $0 sold to date. Dilution here is driven primarily by the S-3 shelf 333-286302, registered to $400,000,000 with $400,000,000 remaining, expiring 2028-04-10.